Everest Medicines Limited - Current Ratio

The Current Ratio as of August 2026 (TTM) for Everest Medicines Limited (1952.HK) is 4.89

According to Everest Medicines Limited’s latest financial reports and current stock price. The company's current Current Ratio is 4.89. This represents a change of -5.45% compared to the average of 5.17 of the last 4 quarters.

Everest Medicines Limited (1952.HK) Historical Current Ratio (quarterly & annually)

How has 1952.HK Current Ratio performed in the past?

The mean historical Current Ratio of Everest Medicines Limited over the last ten years is 6.91. The current 4.89 Current Ratio has changed 6.98% with respect to the historical average. Over the past ten years (40 quarters), 1952.HK's Current Ratio was at its highest in in the March 2021 quarter at 30.22. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Everest Medicines Limited (1952.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Everest Medicines Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Everest Medicines Limited (1952.HK) Average Current Ratio

How has 1952.HK Current Ratio performed in the past?

The current Current Ratio of Everest Medicines Limited (1952.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Everest Medicines Limited (1952.HK) Current Ratio vs. Peers

How is 1952.HK’s Current Ratio compared to its peers?

Everest Medicines Limited’s Current Ratio is greater than Keymed Biosciences Inc. (2.90), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (2.93), greater than Zai Lab Limited (2.13), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (2.15), greater than Nanjing Leads Biolabs Co Ltd (3.37), greater than CStone Pharmaceuticals (2.18), less than InnoCare Pharma Limited (5.65), less than CARsgen Therapeutics Holdings Limited (5.73), greater than CanSino Biologics Inc. (4.11), greater than Ascentage Pharma Group International (1.79),

Build a custom stock screener for Everest Medicines Limited (1952.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Everest Medicines Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Everest Medicines Limited (1952.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Everest Medicines Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.